LY294002 administration caused significant increases in the serum fasting glucose concentration, insulin level and HOMA-IR (P < 0.001) and a decrease in ISI (P < 0.01) in the PCOS + MSCs + LY294002 group compared to the PCOS + MSCs group. This evidence concerns the gene INS and polycystic ovary syndrome.